| Title |
Persistence at 12 months with denosumab in postmenopausal women with osteoporosis: interim results from a prospective observational study
|
|---|---|
| Published in |
Osteoporosis International, September 2014
|
| DOI | 10.1007/s00198-014-2871-6 |
| Pubmed ID | |
| Authors |
S. L. Silverman, E. Siris, D. L. Kendler, D. Belazi, J. P. Brown, D. T. Gold, E. M. Lewiecki, A. Papaioannou, C. Simonelli, I. Ferreira, A. Balasubramanian, P. Dakin, P. Ho, S. Siddhanti, B. Stolshek, C. Recknor |
| Abstract |
To determine persistence with subcutaneous denosumab every 6 months in women being treated for osteoporosis, we conducted a single-arm prospective, observational study in the United States and Canada. Among 935 patients enrolled, 12-month persistence was 82 %, with 66 patients (7 %) reporting serious adverse events and 19 patients (2 %) reporting fractures. |
X Demographics
The data shown below were collected from the profiles of 5 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 3 | 60% |
| Unknown | 2 | 40% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 5 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 84 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| India | 1 | 1% |
| Brazil | 1 | 1% |
| Unknown | 82 | 98% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 16 | 19% |
| Other | 10 | 12% |
| Student > Ph. D. Student | 10 | 12% |
| Researcher | 10 | 12% |
| Student > Master | 8 | 10% |
| Other | 15 | 18% |
| Unknown | 15 | 18% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 38 | 45% |
| Nursing and Health Professions | 9 | 11% |
| Psychology | 7 | 8% |
| Pharmacology, Toxicology and Pharmaceutical Science | 5 | 6% |
| Chemistry | 2 | 2% |
| Other | 7 | 8% |
| Unknown | 16 | 19% |
Attention Score in Context
This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 27 September 2015.
All research outputs
#12,842,966
of 22,764,165 outputs
Outputs from Osteoporosis International
#1,837
of 3,604 outputs
Outputs of similar age
#111,876
of 250,225 outputs
Outputs of similar age from Osteoporosis International
#23
of 91 outputs
Altmetric has tracked 22,764,165 research outputs across all sources so far. This one is in the 43rd percentile – i.e., 43% of other outputs scored the same or lower than it.
So far Altmetric has tracked 3,604 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 7.6. This one is in the 48th percentile – i.e., 48% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 250,225 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 55% of its contemporaries.
We're also able to compare this research output to 91 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 74% of its contemporaries.